Photoallergic erythroderma due to doxycycline therapy of erythema chronicum migrans

Acta Dermato-Venereologica

Volumn 91, Issue 6, 2011, Pages 734-736

  Kuznetsov, Alexander Vasilevic ^a,b,c   Weisenseel, Peter ^a,d   Flaig, Michael Josef ^a   Ruzicka, Thomas ^a   Prinz, Joerg Christoph ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d JANSSEN CILAG GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; CORTICOSTEROID; DIFLUCORTOLONE VALERATE; DIMETINDENE; DOXYCYCLINE; FEXOFENADINE; PREDNICARBATE; SUNSCREEN;

AGED; CASE REPORT; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA CHRONICUM MIGRANS; ERYTHRODERMA; FEMALE; GERIATRIC PATIENT; HUMAN; HYPERTENSION; LETTER; PATCH TEST; PATIENT COUNSELING; PHOTOALLERGY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PRURITUS; RADIATION PROTECTION; SKIN BIOPSY; SKIN INFLAMMATION; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET IRRADIATION;

AGED; DERMATITIS, EXFOLIATIVE; DERMATITIS, PHOTOALLERGIC; DOXYCYCLINE; DRUG ERUPTIONS; ERYTHEMA CHRONICUM MIGRANS; FEMALE; HUMANS;

EID: 80054887151     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1161     Document Type: Letter

References (13)

1. Frost P, Weinstein GD, Gomez EC. Phototoxic potential of minocycline and doxycycline. Arch Dermatol 1972; 105: 681-683.
2. Frank SB, Cohen HJ, Minkin W. Photo-onycholysis due to tetracycline hydrochloride and doxycycline. Arch Dermatol 1971; 103: 520-521.
3. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Safety 2002; 25: 345-372.
4. Stein KR, Scheinfeld NS. Drug-induced photoallergic and phototoxic reactions. Expert Opin Drug Saf 2007; 6: 1-13.
5. Tanaka N, Kawada A, Ohnishi Y, Hiruma M, Tajima S, Akiyama M, et al. Photosensitivity due to doxycycline hydrochloride with an unusual flare. Contact Dermatitis 1997; 37: 93-94.
6. Wienecke R, Neubert U, Volkenandt M. Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffinembedded lesions of Lyme disease. J Cutan Pathol 1993; 20: 385-388.
7. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43: 1089-1134.
8. Rietschel RL, Fowler JF. Photocontact dermatitis. In: Fisher's contact dermatitis. 5th edn, Lippincott Williams & Wilkins, Philadelphia, 2001: p. 397-411.
9. Bruynzeel DP, Ferguson J, Andersen K, Goncalo M, English J, Goossens A, et al. European Task-force for Photopatch Testing. Photopatch testing: a consensus methodology for Europe. J Eur Acad Dermatol Venereol 2004; 18: 679-682.
10. Palmer RY, White IR. Phototoxic and photoallergic reactions. In: Frosch PJ, Menne T, Lepoittevin J-P, editors. Contact dermatitis. 4th edn. Berlin: Springer Verlag, 2006: p. 309-317.
11. Ping-Kai H, Wai-Kwong F. Identification of tetracyclines by second-derivate ultraviolet spectrophotometry. Analyst 1991; 116: 751-752.
12. Wahlberg JE, Lindberg M. Patch testing. In: Frosch PJ, Menne T, Lepoittevin J-P, editors. Contact dermatitis. 4th edn. Berlin: Springer Verlag, 2006: p. 366-390.
13. Aguero-Rosenfeld M, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005; 18: 485-509.